Is melatonin safe for use during pregnancy?

Melatonin Safety During Pregnancy

Due to lack of human safety data, pregnant and breastfeeding women should not take exogenous melatonin at this time.

Current Evidence Status

The available guidelines do not address melatonin use during pregnancy, and the evidence base consists primarily of research studies rather than established clinical practice guidelines. The most comprehensive safety review explicitly recommends against melatonin use in pregnancy due to insufficient human data 1.

Key Safety Considerations

Lack of Regulatory Approval

• Melatonin is classified as a dietary supplement in the United States and is not FDA-approved for any indication 2
• This means it lacks the rigorous safety testing required for medications used during pregnancy
• No standardized dosing, purity, or quality control exists across commercial preparations 3

Human Evidence Limitations

The research evidence presents a mixed picture:

• A 2022 scoping review found that clinical trials using melatonin during pregnancy for various conditions "have not suggested major safety concerns or adverse events" 4
• However, the same review emphasized there is a complete lack of randomized controlled trials examining melatonin specifically for sleep disorders during pregnancy 4
• A 2016 comprehensive safety review concluded that "pregnant and breast-feeding women should not take exogenous melatonin" due to absence of human studies 1

Animal vs. Human Data Discrepancy

The evidence suggests a notable disconnect between animal and human studies:

• Much concern about melatonin in pregnancy stems from animal research 4
• Human clinical studies to date suggest melatonin use during pregnancy "is probably safe in humans" 4
• However, this reassurance is based on limited observational data, not rigorous safety trials 4

Clinical Recommendation

In clinical practice, the absence of evidence is not evidence of safety. Given that:

1. No FDA approval exists for melatonin use during pregnancy
2. No randomized controlled trials have established safety parameters
3. Melatonin crosses the placenta and affects fetal development in animal models
4. Alternative safe sleep interventions exist (sleep hygiene, cognitive behavioral therapy for insomnia)

The prudent approach is to avoid melatonin during pregnancy unless the clinical situation is exceptional and benefits clearly outweigh unknown risks.

Important Caveats

• If a patient has already taken melatonin early in pregnancy, reassure her that available human data has not shown major adverse outcomes 4
• The prevalence of melatonin use in pregnant populations is approximately 4% based on health database surveys 4
• Research studies using melatonin for conditions like preeclampsia prevention have not demonstrated increased neonatal mortality or morbidity 5, 6

The distinction here is critical: lack of demonstrated harm in limited studies does not establish safety for routine clinical use.